The Valley Desk

NCT03347422 · Interventional trial

A Study to Assess the Efficacy and Safety of BIVV009 (Sutimlimab) in Participants With Primary Cold Agglutinin Disease Without A Recent History of Blood Transfusion

Overall registry status Completed

Phase 3

Conditions Cold Agglutinin Disease

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov